The Wall Street Journal: Haleon to Invest $233.5 Million in India Plant Amid Push Into Emerging Markets

Overview

In June 2026, The Wall Street Journal reported on Haleon’s plans to expand its manufacturing footprint in India, highlighting a major investment in oral health production and the company’s broader emerging markets strategy. Key points from the coverage include:

• Major investment in India — Haleon is investing approximately £175 million ($233.5 million) to build its first manufacturing site in India, located in Madhya Pradesh. The facility will produce oral health products and create around 500 jobs.
• Broader emerging markets strategy — The investment forms part of Haleon’s wider push into emerging markets. The company is also exploring acquisitions in higher-growth countries, particularly in the wellness sector, and plans to use learnings from India to support expansion across Latin America, the Middle East and Africa.
• Regional export hub — The new facility will serve not only the Indian market but also export products to 35 countries across Southeast Asia, Japan, South Korea, the Middle East and Australia, strengthening Haleon’s regional supply chain and manufacturing capabilities.

The coverage also quotes CEO Brian McNamara, who emphasised the company’s shift towards growth investment, saying: “We’ve probably done more rationalizing the supply chain, for example shutting down plants rather than investing in creating a new manufacturing footprint.” But now is the time “We’re definitely in investment mode.” He added

McNamara also highlighted India’s role in Haleon’s wider international ambitions, describing it as: “a broad emerging market strategy with India kind of on the tip of the spear.”